Evidence mapPaperPMID 36922895Full record

ArticleMicrobiome2023

Gut microbiota in a mouse model of obesity and peripheral neuropathy associated with plasma and nerve lipidomics and nerve transcriptomics.

Kai Guo, Claudia Figueroa-Romero, Mohamed Noureldein, Lucy M Hinder, Stacey A Sakowski, Amy E Rumora, Hayley Petit, Masha G Savelieff, Junguk Hur, Eva L Feldman

Open access · goldFull text readVideo-Audio Media
In one paragraph

Article in Microbiome, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Effect of AG1Frontiers in nutrition · 2026
    Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Kai Guo *Department of Neurology, University of Michigan, Ann Arbor, MI, 48109, USA.
Claudia Figueroa-Romero *Department of Neurology, University of Michigan, Ann Arbor, MI, 48109, USA.
Mohamed Noureldein *Department of Neurology, University of Michigan, Ann Arbor, MI, 48109, USA.
Lucy M HinderDepartment of Neurology, University of Michigan, Ann Arbor, MI, 48109, USA.
Stacey A SakowskiDepartment of Neurology, University of Michigan, Ann Arbor, MI, 48109, USA.
Amy E RumoraDepartment of Neurology, University of Michigan, Ann Arbor, MI, 48109, USA.
Hayley PetitDepartment of Neurology, University of Michigan, Ann Arbor, MI, 48109, USA.
Masha G SavelieffDepartment of Neurology, University of Michigan, Ann Arbor, MI, 48109, USA.
Junguk HurDepartment of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND, 58202, USA.
Eva L FeldmanDepartment of Neurology, University of Michigan, Ann Arbor, MI, 48109, USA. efeldman@umich.edu.
University of Michigan · USReata Pharmaceuticals (United States) · USUniversity of North Dakota · US

Funding

Mapping the ALS Exposome to Gain New Insights into Disease Risk and PathogenesisR01ES030049 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI STUART A BATTERMAN, Eva Lucille Feldman · 2022 to 2024
$2.0M
NIDDK NIH HHS F32 DK112642NIDDK NIH HHS K99 DK119366NIDDK NIH HHS R00 DK119366NIDDK NIH HHS R24 DK082841NIDDK NIH HHS U24 DK115255NIEHS NIH HHS R01 ES030049NIH HHS F32DK112642NIH HHS R01ES030049NIH HHS R21NS102924NIH HHS R24DK082841NIH HHS U24DK115255NINDS NIH HHS R21 NS102924
6 · The paper itself

Abstract

backgroundPeripheral neuropathy (PN) is a common complication in obesity, prediabetes, and type 2 diabetes, though its pathogenesis remains incompletely understood. In a murine high-fat diet (HFD) obesity model of PN, dietary reversal (HFD-R) to a low-fat standard diet (SD) restores nerve function and the nerve lipidome to normal. As the gut microbiome represents a potential link between dietary fat intake and nerve health, the current study assessed shifts in microbiome community structure by 16S rRNA profiling during the paradigm of dietary reversal (HFD-R) in various gut niches. Dietary fat content (HFD versus SD) was also correlated to gut flora and metabolic and PN phenotypes. Finally, PN-associated microbial taxa that correlated with the plasma and sciatic nerve lipidome and nerve transcriptome were used to identify lipid species and genes intimately related to PN phenotypes.

resultsMicrobiome structure was altered in HFD relative to SD but rapidly reversed with HFD-R. Specific taxa variants correlating positively with metabolic health associated inversely with PN, while specific taxa negatively linked to metabolic health positively associated with PN. In HFD, PN-associated taxa variants, including Lactobacillus, Lachnoclostridium, and Anaerotruncus, also positively correlated with several lipid species, especially elevated plasma sphingomyelins and sciatic nerve triglycerides. Negative correlations were additionally present with other taxa variants. Moreover, relationships that emerged between specific PN-associated taxa variants and the sciatic nerve transcriptome were related to inflammation, lipid metabolism, and antioxidant defense pathways, which are all established in PN pathogenesis.

conclusionsThe current results indicate that microbiome structure is altered with HFD, and that certain taxa variants correlate with metabolic health and PN. Apparent links between PN-associated taxa and certain lipid species and nerve transcriptome-related pathways additionally provide insight into new targets for microbiota and the associated underlying mechanisms of action in PN. Thus, these findings strengthen the possibility of a gut-microbiome-peripheral nervous system signature in PN and support continuing studies focused on defining the connection between the gut microbiome and nerve health to inform mechanistic insight and therapeutic opportunities. Video Abstract.

Indexed as

Diabetes Mellitus, Type 2Gastrointestinal MicrobiomePeripheral Nervous System DiseasesAnimalsDietary FatsDiet, High-FatDisease Models, AnimalLipidomicsLipidsMiceMice, Inbred C57BLObesityRNA, Ribosomal, 16STranscriptomeDietary FatsLipidsRNA, Ribosomal, 16SDysbiosisLipidsMicrobiomeObesityOmicsPeripheral neuropathyPrediabetes

Identifiers

PMID36922895
PMCPMC10015923
OpenAlexW4324379802

What Socratic holds

Textfull text, public
LicenceCC BY
measurements read22
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.